Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Recruiting · NCT05997615 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 | 2026-10-07 | NCT05997615 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Astellas Pharma Global Development, Inc. | 43 |
| Vir Biotechnology, Inc. | 9 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chicago Cancer Center | Zion | United States | 1 |
| Duarte Cancer Center | Duarte | United States | 2 |
| ES34007 | Barcelona | Spain | 1 |
| ES34009 | Valencia | Spain | 1 |
| ES34010 | Logroño | Spain | 1 |
| ES34012 | Madrid | Spain | 1 |
| ES34013 | Málaga | Spain | 1 |
| GB44003 | Leicester | United Kingdom | 1 |
| Lennar Foundation Cancer Center | Irvine | United States | 1 |
| UCI Health Chao Family Comprehensive Cancer Center | Orange | United States | 1 |